Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

November 30, 2004

Conditions
Breast Cancer
Interventions
DRUG

fluorouracil

DRUG

vinorelbine tartrate

Trial Locations (17)

2010

VZW Monica Campus Eeuwfeestkliniek, Antwerp

10043

Azienda Ospedale S. Luigi - Universita Di Turin, Orbassano, (Torino)

10180

Istituto per la Ricerca e Cura del Cancro, Candiolo (Turin)

20153

Ospedale San Carlo Borromeo, Milano (Milan)

21079

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon

42055

Hopital Bellevue, Saint-Etienne

63011

Centre Jean Perrin, Clermont-Ferrand

71110

University Hospital of Heraklion, Iraklion (Heraklion)

75475

Hopital Saint-Louis, Paris

87042

Centre Hospital Regional Universitaire de Limoges, Limoges

92211

Centre Rene Huguenin, Saint-Cloud

92300

Hopital Perpetuel Secours, Levallois-Perret

94804

Hopital Paul Brousse, Villejuif

B 4000

C.H.C - Asbl, Liège

B-4000

CHU Liege - Domaine Universitaire du Sart Tilman, Liège

I-27100

Fondazione Salvatore Maugeri, Pavia

00161

Istituti Fisioterapici Ospitalieri - Roma, Rome

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00003730 - Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter